| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |